Why the study?
Extrapolating cardiac resynchronization therapy to pediatric heart failure patients is challenging due to heterogeneity in cardiomyopathies, congenital heart disease substrates, and conduction abnormalities.
Does cardiac resynchronization therapy improve outcomes in pediatric and young adult patients with heart failure and congenital heart disease?
Does cardiac resynchronization therapy improve outcomes in pediatric and young adult patients with heart failure and congenital heart disease?
CRT shows promise in specific pediatric heart failure subpopulations, highlighting the need for collaborative patient selection based on electrical and mechanical dyssynchrony.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mitchell I. Cohen (2015) conducted a review in Pediatric heart failure and congenital heart disease. Cardiac resynchronization therapy (CRT) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: